Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersOphthalmology Physician in Chesterfield, MO
NPI: 1124010434Primary Practice Location
Mid- America Surgery Center, LLC
1815 Clarkson Rd, Chesterfield, MO
Primary Employer
Pepose Vision Institute, PC
peposevision.com
HQ Phone
Get M.D. Mujtaba's Phone Numberphone_androidMobile
Get M.D. Mujtaba's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92012Eye and medical examination for diagnosis and treatment, established patient | 403 | 801 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 396 | 403 |
| 3 | 92133Diagnostic imaging of optic nerve of eye | 195 | 200 |
| 4 | 92136Measurement of corneal curvature and depth of eye | 175 | 182 |
| 5 | 92083Measurement of field of vision during daylight conditions | 153 | 156 |
Benefits and barriers of accommodating intraocular lenses.
Authors: Pepose, Jay S, Burke, Joshua, Qazi, Mujtaba A
Journal: Curr Opin Ophthalmol
Objective Quantification of Image Quality and Optical Scatter Before and After Nd:YAG Capsulotomy Using a Double-Pass Technique.
Authors: Abu-Bakar Zafar
Publication Date: 2020-06-18
The Influence of Tomographic Corneal Characteristics on Epithelial Thickness Profile.
Authors: Hashmani, Nauman, Hashmani, Maria, Hashmani, Sharif, Fatima, Kiran, Farid, Neha, Zakaria, Faiza, Qazi, Mujtaba A
Journal: Cureus
Publication Date: 2020-11-27
Lead Sponsor: LensGen, Inc.
Intervention / Treatment: DEVICE: Juvene IOL, DEVICE: Tecnis® Monofocal (ZCB00, PCB00 or DCB00)
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Lifitegrast 5% Ophthalmic Solution, DRUG: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), DRUG: Mycophenolic Acid 0.1%, DRUG: Mycophenolic Acid 0.3%, DRUG: Betamethasone Sodium Phosphate 0.01%, DRUG: Placebo Comparator: Vehicle, DRUG: Cyclosporine 0.05% Ophthalmic Emulsion
Lead Sponsor: AcuFocus, Inc.
Intervention / Treatment: DEVICE: Control Group, DEVICE: IC-8 IOL Group
